Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG as Booster for Salmonella Typhi Vaccine
NCT02175420Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2012
- Primary completion
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of bcg vaccine in typhoid fever (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Anti-Salmonella Typhi Vi antigen antibody titer at 3 months. Started Jul 2012; status: completed.
02
Drugs
bcg vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT02175420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175420.